Collaborators‎ > ‎

Sarah Benki-Nugent, PhD, Acting Instructor


Dr. Benki-Nugent received her PhD (Microbiology) and MS (Epidemiology) from the University of Washington.  She has been involved in HIV research in Kenya since 2000.  Her broad research goals are to improve health outcomes in HIV-infected children in international settings.  Her studies will examine the extent and correlates of neurocognitive impairment in HIV-infected children who either received antiretroviral therapy (ART) from infancy or who were HIV-diagnosed later in childhood.  For the past several years, she has been a co-investigator for several studies involving HIV-infected children in Kenya, including the Optimizing Pediatric HIV-1 Therapy 03 study, which examined continued versus interrupted ART in children and the Pediatric Urgent Start of HAART study, which will determine optimal timing of ART in hospitalized children.


 




Representative Publications
 
1. Wamalwa D*, Benki-Nugent S*, Langat A, Tapia, K, Ngugi, E, Slyker J, Richardson BS, John-Stewart GC. Survival benefit of early infant antiretroviral therapy is compromised when HIV-1 diagnosis is delayed. Ped Inf Dis J.  2012 Apr 26. [Epub ahead of print].

2. Benki-Nugent S, Chung MH, Ackers M, Richardson BA, McGrath CJ, Kohler P, Thiga J, Attwa M, John-Stewart GC. Knowing a sexual partner is HIV-1-uninfected is associated with higher condom use among HIV-1-infected adults in Kenya. Sex Transm Dis 2011 Sep;38(9):808-10. [PMCID In Process]

 3. Wamalwa DC, Obimbo EM, Farquhar C, Richardson BA, Mbori-Ngacha DA, Inwani  I, Benki-Nugent S, John-Stewart G. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: A prospective cohort.  BMC  Pediatr  2010 10(1):33. [PMID 20482796]

Comments